LO FRANCIS
SEC CIK 1780660 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ADPT | Adaptive Biotechnologies Corp | CHRO | 336.3K | — | $13.53M | 32 | 2022-03-04 | 2026-09-16 |
Most active insiders at ADPT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ROBINS CHAD M | CEO, COB, Dir | — | $39.80M |
| 2 | ROBINS HARLAN S | CSO | — | $29.65M |
| 3 | BENZENO SHARON | Chief Commercial Ofc Imm Med | — | $14.69M |
| 4 | RUBINSTEIN JULIE | Pres, COO | — | $13.37M |
| 5 | LO FRANCIS | CHRO | — | $13.21M |
| 6 | PISKEL KYLE | CFO | — | $3.58M |
| 7 | NEUPERT PETER M | Dir | — | $3.14M |
| 8 | GRIFFIN MICHELLE RENEE | Dir | — | $2.00M |
| 9 | BOBULSKY SUSAN | Chief Commercial Off, MRD | — | $1.20M |
| 10 | HERSHBERG ROBERT | Dir | — | $1.12M |
Transactions 32
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-09-18 20:17 | 2026-09-16 | ADPT | Adaptive Biotechnologies Corp | LO FRANCIS | CHRO | M - OptEx | $9.57 | +105.6K | 336.3K | +46% | +$1.01M |
| DMT | 2026-09-18 20:17 | 2026-09-16 | ADPT | Adaptive Biotechnologies Corp | LO FRANCIS | CHRO | S - Sale+OE | $28.06 | -115.4K | 220.9K | -34% | -$3.24M |
| DMT | 2026-07-17 19:23 | 2026-07-15 | ADPT | Adaptive Biotechnologies Corp | LO FRANCIS | CHRO | M - OptEx | $8.91 | +105.8K | 336.5K | +46% | +$942.7K |
| DT | 2026-07-17 19:23 | 2026-07-15 | ADPT | Adaptive Biotechnologies Corp | LO FRANCIS | CHRO | S - Sale+OE | $22.59 | -105.8K | 230.7K | -31% | -$2.39M |
| DMT | 2026-07-06 19:19 | 2026-07-01+ | ADPT | Adaptive Biotechnologies Corp | LO FRANCIS | CHRO | M - OptEx | $8.75 | +75.6K | 275.6K | +38% | +$661.9K |
| DMT | 2026-07-06 19:19 | 2026-07-01+ | ADPT | Adaptive Biotechnologies Corp | LO FRANCIS | CHRO | S - Sale+OE | $22.51 | -95.8K | 230.7K | -29% | -$2.16M |
| DMT | 2026-06-08 20:29 | 2026-06-04 | ADPT | Adaptive Biotechnologies Corp | LO FRANCIS | CHRO | M - OptEx | $8.85 | +19.5K | 290.7K | +7% | +$172.8K |
| DT | 2026-06-08 20:29 | 2026-06-04 | ADPT | Adaptive Biotechnologies Corp | LO FRANCIS | CHRO | S - Sale+OE | $17.49 | -39.7K | 250.9K | -14% | -$695.1K |
| DT | 2026-04-10 18:52 | 2026-04-08 | ADPT | Adaptive Biotechnologies Corp | LO FRANCIS | CHRO | M - OptEx | $3.99 | +2,344 | 293.7K | +0.8% | +$9,353 |
| DT | 2026-04-10 18:52 | 2026-04-08 | ADPT | Adaptive Biotechnologies Corp | LO FRANCIS | CHRO | S - Sale+OE | $15.07 | -22.6K | 271.2K | -8% | -$340.0K |
| 2026-03-13 | 2026-03-11 | ADPT | Adaptive Biotechnologies Corp | LO FRANCIS | CHRO | S - Sale | $14.08 | -30.6K | 291.4K | -10% | -$430.7K | |
| 2026-03-09 | 2026-03-05 | ADPT | Adaptive Biotechnologies Corp | LO FRANCIS | CHRO | S - Sale | $15.09 | -38.1K | 322.0K | -11% | -$574.5K | |
| 2026-03-06 | 2026-03-04 | ADPT | Adaptive Biotechnologies Corp | LO FRANCIS | CHRO | A - Grant | $0.00 | +44.1K | 360.0K | +14% | $0 | |
| DM | 2026-01-14 | 2026-01-12 | ADPT | Adaptive Biotechnologies Corp | LO FRANCIS | CHRO | M - OptEx | $7.71 | +79.6K | 395.6K | +25% | +$614.0K |
| D | 2026-01-14 | 2026-01-12 | ADPT | Adaptive Biotechnologies Corp | LO FRANCIS | CHRO | S - Sale+OE | $17.73 | -79.6K | 316.0K | -20% | -$1.41M |
| DA | 2026-01-07 | 2025-12-22 | ADPT | Adaptive Biotechnologies Corp | LO FRANCIS | CHRO | S - Sale+OE | $17.50 | -4,394 | 316.0K | -1% | -$76.9K |
| DMA | 2026-01-07 | 2025-12-22 | ADPT | Adaptive Biotechnologies Corp | LO FRANCIS | CHRO | M - OptEx | $6.06 | +4,394 | 317.1K | +1% | +$26.6K |
| D | 2026-01-06 | 2026-01-02 | ADPT | Adaptive Biotechnologies Corp | LO FRANCIS | CHRO | S - Sale+OE | $16.08 | -3,125 | 316.0K | -1.0% | -$50.2K |
| D | 2026-01-06 | 2026-01-02 | ADPT | Adaptive Biotechnologies Corp | LO FRANCIS | CHRO | M - OptEx | $3.99 | +3,125 | 319.1K | +1.0% | +$12.5K |
| D | 2025-12-29 | 2025-12-22 | ADPT | Adaptive Biotechnologies Corp | LO FRANCIS | CHRO | S - Sale+OE | $17.50 | -4,394 | 316.0K | -1% | -$76.9K |
| DM | 2025-12-29 | 2025-12-22 | ADPT | Adaptive Biotechnologies Corp | LO FRANCIS | CHRO | M - OptEx | $7.18 | +4,394 | 319.3K | +1% | +$31.5K |
| DM | 2025-12-17 | 2025-12-15 | ADPT | Adaptive Biotechnologies Corp | LO FRANCIS | CHRO | M - OptEx | $6.37 | +97.0K | 429.9K | +29% | +$617.8K |
| D | 2025-12-17 | 2025-12-15 | ADPT | Adaptive Biotechnologies Corp | LO FRANCIS | CHRO | S - Sale+OE | $15.57 | -113.9K | 316.0K | -26% | -$1.77M |
| D | 2025-03-06 | 2025-03-04 | ADPT | Adaptive Biotechnologies Corp | LO FRANCIS | CHRO | A - Grant | $0.00 | +100.0K | 353.7K | +39% | $0 |
| DM | 2025-03-06 | 2025-03-05 | ADPT | Adaptive Biotechnologies Corp | LO FRANCIS | CHRO | S - Sale | $6.99 | -20.9K | 346.6K | -6% | -$145.8K |
| DM | 2024-03-06 | 2024-03-05 | ADPT | Adaptive Biotechnologies Corp | LO FRANCIS | CHRO | S - Sale | $3.43 | -14.7K | 253.7K | -5% | -$50.4K |
| D | 2024-03-06 | 2024-03-04 | ADPT | Adaptive Biotechnologies Corp | LO FRANCIS | CHRO | A - Grant | $0.00 | +100.0K | 268.4K | +59% | $0 |
| D | 2023-03-08 | 2023-03-06 | ADPT | Adaptive Biotechnologies Corp | LO FRANCIS | CHRO | S - Sale | $8.57 | -6,816 | 168.5K | -4% | -$58.4K |
| D | 2023-03-08 | 2023-03-06 | ADPT | Adaptive Biotechnologies Corp | LO FRANCIS | CHRO | A - Grant | $0.00 | +85.7K | 175.3K | +96% | $0 |
| 2022-03-10 | 2022-03-08 | ADPT | Adaptive Biotechnologies Corp | LO FRANCIS | CHRO | S - Sale | $11.44 | -3,582 | 89.6K | -4% | -$41.0K | |
| D | 2022-03-08 | 2022-03-04 | ADPT | Adaptive Biotechnologies Corp | LO FRANCIS | CHRO | A - Grant | $0.00 | +74.1K | 94.7K | +360% | $0 |
| D | 2022-03-08 | 2022-03-07 | ADPT | Adaptive Biotechnologies Corp | LO FRANCIS | CHRO | S - Sale | $12.01 | -1,569 | 93.2K | -2% | -$18.8K |
Purchase Sale Sale after option exercise All abbreviations